Corrigendum to "Integrative analysis of anoikis-related genes prognostic signature with immunotherapy and identification of CDKN3 as a key oncogene in lung adenocarcinoma" [ Int. Immunopharmacol. 143 (2024) 113282]
Int Immunopharmacol. 2024 Nov 22:113584.
doi: 10.1016/j.intimp.2024.113584.
Online ahead of print.
1 National & Local Joint Engineering Research Center of Orthopaedic Biomaterials, Peking University Shenzhen Hospital, Shenzhen 518036, China; Shenzhen Key Laboratory of Orthopaedic Diseases and Biomaterials Research, Shenzhen 518036, China; Department of Bone & Joint Surgery, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen 518036, China.
2 Department of Thoracic Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, China.
3 Department of Oncology, Chaohu Hospital of Anhui Medical University, Hefei 238001, China.
4 Department of Thoracic Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, China. Electronic address: liujx0417@163.com.
5 National & Local Joint Engineering Research Center of Orthopaedic Biomaterials, Peking University Shenzhen Hospital, Shenzhen 518036, China; Shenzhen Key Laboratory of Orthopaedic Diseases and Biomaterials Research, Shenzhen 518036, China; Department of Bone & Joint Surgery, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen 518036, China. Electronic address: yufei89@pku.edu.cn.
6 Department of Radiology, Peking University Shenzhen Hospital, Shenzhen 518036, China. Electronic address: junyang@pkuszh.com.